Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 8, 2004, Pages 847-853

  Kim, Kyun Hwan ^a   Sang, Hoon Ahn ^a,b   Hyo, Young Chung ^b   Yong, Han Paik ^a,b   Kwan, Sik Lee ^b   Yu, Seun Kim ^a,b   Chae, Yoon Chon ^b   Young, Myoung Moon ^a   Han, Kwang Hyub ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

'a' determinant mutants; Antibody to hepatitis B surface antigen immunity; Hepatitis B virus infection; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SEQUENCE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER FAILURE; MALE; MOLECULAR CLONING; MORTALITY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS IMMUNITY; VIRUS MUTATION; WILD TYPE;

EID: 4143148407     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2003.03303.x     Document Type: Article

References (43)

1. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 1991; 13: 619-26.
2. Perillo R, Mason A. Hepatitis B and liver transplantation. Problems and promises. N. Engl. J. Med. 1993; 329: 1885-7.
3. Laskus T, Rakela J, Seers JL, Wiesner RH, Persing DH. Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B. Gastroenterology 1994; 107: 1774-80.
4. McMahon G, Ehrlich PH, Moustafa ZA et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757-66.
5. Cariani E, Ravaggi A, Tanzi E et al. Emergence of hepatitis B virus S gene mutant in a liver transplant recipient. J. Med. Virol. 1995; 47: 410-15.
6. Carman WF, Trautwein C, van Deursen FJ et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24: 489-93.
7. Hawkins A, Gilson R, Gilbert N et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J. Hepatol. 1996; 24: 8-14.
8. Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-9.
9. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR. A novel hepatitis B virus variant in the sera of immunized children. J. Gen. Virol. 1994; 75: 443-8.
10. Oon CJ, Lim GK, Ye Z et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995; 13: 699-702.
11. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J. Hepatol. 1991; 13 (Suppl. 4): S105-7.
12. Okamoto H, Yano K, Nozaki Y et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr. Res. 1992; 32: 264-8.
13. Protzer-Knolle U, Naumann U, Bartenschlager R et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27: 254-63.
14. Mangold CM, Unckell F, Werr M, Streeck RE. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 1995; 211: 535-43.
15. Mangold CM, Streeck RE. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J. Virol. 1993; 67: 4588-97.
16. Fairley CK, Mijch a, Gust ID, Nichilson S, Dimitrakakis M, Lucas CR. The increased risk of fatal liver disease in renal transplant patients who are hepatitis B e antigen and/or HBV DNA positive. Transplantation 1991; 52: 497-500.
17. Harnett JD, Zeldis JB, Parfrey PS et al. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation 1987; 44: 369-76.
18. Gunther S, Baginski S, Kissel H et al. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology 1996; 24: 751-8.
19. Preikschat P, Gunther S, Reinhold S et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002; 35: 466-77.
20. Terrault NA, Zhou S, McCory RW et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 1998; 28: 555-61.
21. Fujii H, Moriyama K, Sakamoto N et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem. Biophys. Res. Comm. 1992; 184: 1152-7.
22. Zuckermann AJ, Harrison TJ, Oon CJ. Mutants in the S region of hepatitis B virus. Lancet 1994; 343: 737-8.
23. Hino K, Okuda M, Hashimoto O et al. Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Dig. Dis. Sci. 1995; 40: 566-70.
24. Wallace LA, Echevarria JE, Echevarria JM, Carmnan WF. Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J. Infect. Dis 1994; 170: 1300-3.
25. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995; 345: 1406-7.
26. Ljunggren KK, Hansson BG, Wallmark E, Croxson MC, Kidd AH, Nordenfelt E. Reactivation of hepatitis B virus infection with an unusual pattern of serological markers. Scand. J. Infect. Dis 1992; 24: 657-60.
27. Preisler-Adams S, Schlayer HJ, Peters T, Hettler F, Gerok W, Rasenack J. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch. Virol. 1993; 133: 385-96.
28. Cooreman MP, Leroux-Roels G, Paulij WP. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed. Sci. 2001; 8: 237-47.
29. Fischer L, Kalinina T, Rogiers X, Will H, Sterneck M. GLY145ARG mutation emerging under HBIg treatment in patients with recurrent HBV after liver transplantation strongly reduces viral secretion. Transplant. Proc. 2001; 33: 3633-6.
30. Ghany MG, Ayola B, Villamil FG et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27: 213-22.
31. Moriyama K, Nakajima E, Hohjoh H, Asayama R, Okochi K. Immunoselected hepatitis B virus mutant. Lancet 1991; 337: 125.
32. Sastrosoewignjo RI, Sandjaja B, Okamoto H. Molecular epidemiology of hepatitis B virus in Indonesia. J. Gastroenterol. Hepatol. 1991; 6: 491-8.
33. Pride MW, Thanavala YM, Strick N, Houghten RA, Neurath AR. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S (122-136). Pept. Res. 1992; 5: 217-26.
34. Waters JA, Kennedy M, Voet P et al. Loss of the common 'A' determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Invest. 1992; 90: 2543-7.
35. Motti C, Nuzzo M, Meola A et al. Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene 1994; 146: 191-8.
36. Steward MW, Partidos CD, D'Mello F, Howard CR. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides. Vaccine 1993; 11: 1405-14.
37. Bhatnagar PK, Papasi E, Blum HE et al. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc. Natl. Acad. Sci. USA 1982; 79: 4400-4.
38. Neurath AR, Pride MW, Strick N, Thanavala YM. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S (139-147). Pept. Res. 1990; 3: 116-22.
39. Norder H, Courouce AM, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J. Gen. Virol. 1992; 73: 3141-5.
40. Norder H, Hammas B, Lee SD et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J. Gen. Virol. 1993; 74: 1341-8.
41. Okamoto H, Tsuda F, Sakugawa H et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol. 1988; 69: 2575-83.
42. Lauder IJ, Lin HJ, Lau JY, Siu TS, Lai CL. The variability of the hepatitis B virus genome: statistical analysis and biological implications. Mol. Biol. Evol. 1993; 10: 457-70.
43. Yuki N, Nagaoka T, Yamashiro M et al. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 2003; 37: 1172-9.